checkmate-142: updated data from msi high metastatic colon cancer patients
Published 5 years ago • 158 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
4:31
checkmate142: checkpoint combination therapy in first-line colorectal cancer
-
2:03
promising checkmate-142 data for second-line ipilimumab plus nivolumab in mcrc
-
5:59
nivolumab plus low-dose ipilimumab promising for treatment-naïve msi-high mcrc | heinz-josef lenz
-
2:37
moving forward with results from checkmate-142 in msi-h mcrc
-
1:11
checkmate-8hw: nivolumab and ipilimumab in msi-h/dmmr mcrc
-
3:44
keynote-177 & checkmate 142: checkpoint blockade in msi-h/dmmr crc
-
2:33
updated results for nivolumab in msi-h colorectal cancer
-
1:11
nivolumab/ipilimumab combination data promising in msi-h/dmmr mcrc
-
3:10
case 4: metastatic colon cancer, msi-high
-
9:25
debate: msi high colon cancer - immunotherapy
-
1:03
dr. nelson on the checkmate-142 trial in msi-h/dmmr mcrc
-
5:19
targeting braf v600e in metastatic colorectal cancer: where are we today?
-
15:55
should msi be determined in all patients with stage ii and iii colon cancer patients?
-
5:20
pembrolizumab improves on chemo in msi-h/dmmr mcrc
-
9:40
microsatellite instability status in colorectal cancer
-
6:03
checkmate 9la: nivolumab, ipilimumab and chemotherapy for stage iv nsclc
-
1:14
current and future trends in immunotherapy for msi-h colorectal cancer
-
5:56
results from checkmate-032, nivolumab and ipilimumab for melanoma
-
21:35
colorectal cancer: msi testing to all patients and how to test